Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Nasally delivered flu vaccine safe and immunogenic in adults

Oct. 30, 1998

Phase III study evaluates efficacy of tacrolimus in bone marrow transplantation

Oct. 29, 1998

Aquila's malaria vaccine immunogenic and well tolerated in phase I trial

Oct. 28, 1998

Vasogen files for protection of patient-specific treatment of GvHD

Oct. 27, 1998

Simulect gets the go-ahead from the European Commission

Oct. 23, 1998

Astra patents novel immunosuppressive agents

Oct. 22, 1998

Oxo Chemie initiates phase III trial of compound for late-stage HIV infection

Oct. 21, 1998

Ribi, ATL collaborate on the development of improved allergy vaccines

Oct. 20, 1998

Certiva vaccine launched in the U.S.

Oct. 16, 1998

Orphan drug designation granted to MEDI-507 for use in AlloMune system

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...